{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T18:31:06Z","timestamp":1787941866758,"version":"build-2784847793"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1001\/jamainternmed.2018.3638","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:36:45Z","timestamp":1536014205000},"page":"1380","source":"Crossref","is-referenced-by-count":32,"title":["Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital"],"prefix":"10.1001","volume":"178","author":[{"given":"Lelia H.","family":"Chaisson","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Duong","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[{"name":"Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marguerite","family":"Roemer","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Department of Laboratory Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Handley","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco"},{"name":"Division of General Internal Medicine, University of California, San Francisco, San Francisco"},{"name":"UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Schillinger","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of California, San Francisco, San Francisco"},{"name":"UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sur","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phong","family":"Pham","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Department of Laboratory Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Department of Laboratory Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Elizabeth","family":"Goldman","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Quan","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of California, San Francisco, San Francisco"},{"name":"UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saida","family":"Perez","sequence":"additional","affiliation":[{"name":"Division of Pulmonary & Critical Care Medicine, Department of Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Healy","sequence":"additional","affiliation":[{"name":"Division of Hospital Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Higashi","sequence":"additional","affiliation":[{"name":"Department of Public Health, Los Angeles County, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Winston","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Haller","sequence":"additional","affiliation":[{"name":"Division of Microbiology, Department of Laboratory Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California"},{"name":"Department of Laboratory Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne F.","family":"Luetkemeyer","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Lucian","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut"},{"name":"Pulmonary, Critical Care, and Sleep Medicine Section, Department of Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"34","key":"ioi180053r1","first-page":"585","article-title":"Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons\u2014Florida and New York, 1988-1991.","volume":"40","author":"Centers for Disease Control (CDC)","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"ioi180053r2","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1001\/jama.1992.03490100078031","article-title":"Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients.","volume":"268","author":"Beck-Sagu\u00e9","year":"1992","journal-title":"JAMA"},{"issue":"23","key":"ioi180053r3","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJM199206043262302","article-title":"An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome.","volume":"326","author":"Edlin","year":"1992","journal-title":"N Engl J Med"},{"issue":"RR-13","key":"ioi180053r4","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994.","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"MMWR Recomm Rep"},{"issue":"RR-17","key":"ioi180053r5","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"ioi180053r6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.7326\/0003-4819-122-2-199501150-00002","article-title":"Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers.","volume":"122","author":"Maloney","year":"1995","journal-title":"Ann Intern Med"},{"issue":"11","key":"ioi180053r7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1086\/502141","article-title":"Prevalence of tuberculin skin test positivity and conversions among healthcare workers in New York City during 1994 to 2001.","volume":"24","author":"Cook","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"ioi180053r8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1164\/rccm.200803-381OC","article-title":"Feasibility of shortening respiratory isolation with a single sputum nucleic acid amplification test.","volume":"178","author":"Campos","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"ioi180053r9","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance.","volume":"363","author":"Boehme","year":"2010","journal-title":"N Engl J Med"},{"issue":"10","key":"ioi180053r10","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/cid\/ciu620","article-title":"Impact of GeneXpert MTB\/RIF assay on triage of respiratory isolation rooms for inpatients with presumed tuberculosis: a hypothetical trial.","volume":"59","author":"Chaisson","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ioi180053r11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/cid\/ciu212","article-title":"Xpert MTB\/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States.","volume":"59","author":"Lippincott","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ioi180053r12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1017\/ice.2018.25","article-title":"Use of a single Xpert MTB\/RIF assay to determine the duration of airborne isolation in hospitalized patients with suspected pulmonary tuberculosis.","volume":"39","author":"Poonawala","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"ioi180053r13","doi-asserted-by":"publisher","first-page":"e79669","DOI":"10.1371\/journal.pone.0079669","article-title":"Rapid molecular testing for TB to guide respiratory isolation in the U.S.: a cost-benefit analysis.","volume":"8","author":"Millman","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ioi180053r14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/cid\/ciw803","article-title":"Clinical impact and cost-effectiveness of Xpert MTB\/RIF testing in hospitalized patients with presumptive pulmonary tuberculosis in the United States.","volume":"64","author":"Cowan","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ioi180053r15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/cid\/ciw035","article-title":"Evaluation of Xpert MTB\/RIF versus AFB smear and culture to identify pulmonary tuberculosis in patients with suspected tuberculosis from low and higher prevalence settings.","volume":"62","author":"Luetkemeyer","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"ioi180053r16","first-page":"193","article-title":"Revised device labeling for the Cepheid Xpert MTB\/RIF assay for detecting mycobacterium tuberculosis.","volume":"64","author":"Division of Microbiology Devices, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"ioi180053r18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda.","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Policy Ment Health"},{"issue":"1","key":"ioi180053r21","first-page":"CD009593","article-title":"Xpert MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.","author":"Steingart","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ioi180053r22","first-page":"7","article-title":"Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis.","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"ioi180053r24","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1370\/afm.1713","article-title":"From triple to quadruple aim: care of the patient requires care of the provider.","volume":"12","author":"Bodenheimer","year":"2014","journal-title":"Ann Fam Med"},{"key":"ioi180053r26","doi-asserted-by":"publisher","first-page":"h2147","DOI":"10.1136\/bmj.h2147","article-title":"The PRECIS-2 tool: designing trials that are fit for purpose.","volume":"350","author":"Loudon","year":"2015","journal-title":"BMJ"},{"key":"ioi180053r27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13012-014-0096-x","article-title":"How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research.","volume":"9","author":"Gaglio","year":"2014","journal-title":"Implement Sci"},{"key":"ioi180053r17","unstructured":"National TB Controllers Association and the Association of Public Health Laboratories. Consensus statement on the use of cepheid Xpert MTB\/RIF assay in making decisions to discontinue airborne infection isolation in healthcare settings. 2015. http:\/\/www.tbcontrollers.org\/resources\/airborne-infection-isolation\/#.Wzbz99MbOfU. Accessed April 9, 2018."},{"key":"ioi180053r19","unstructured":"Introducing Xpert MTB\/RIF Testing for Active Pulmonary TB at Zuckerberg San Francisco General | San Francisco Health Network (SFHN). San Francisco Health Network (SFHN). http:\/\/www.sfhealthnetwork.org\/xpertmtb\/. Accessed April 5, 2018."},{"key":"ioi180053r20","unstructured":"Centers for Medicare and Medicaid Services. Principles of Reasonable Cost Reimbursement: 42 C.F.R. \u00a7 413.20 and 413.24. https:\/\/www.gpo.gov\/fdsys\/pkg\/CFR-2002-title42-vol2\/xml\/CFR-2002-title42-vol2-part413-subpartB.xml. Accessed April 5, 2018."},{"key":"ioi180053r23","unstructured":"Institute of Medicine. Leading Health Indicators for Healthy People 2020: Letter Report. 2011. https:\/\/www.nap.edu\/catalog\/13088\/leading-health-indicators-for-healthy-people-2020-letter-report. Accessed April 9, 2018."},{"key":"ioi180053r25","unstructured":"Healthy People 2020. IID-32 Data Details | Healthy People 2020. https:\/\/www.healthypeople.gov\/node\/4702\/data_details. Accessed May 22, 2018."}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2697838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T20:54:20Z","timestamp":1751835260000},"score":1,"resource":{"primary":{"URL":"http:\/\/archinte.jamanetwork.com\/article.aspx?doi=10.1001\/jamainternmed.2018.3638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2018.3638","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,1]]}}}